# Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

> **NCT06920316** · PHASE4 · NOT_YET_RECRUITING · sponsor: **St. George's Hospital, London** · enrollment: 100 (estimated)

## Conditions studied

- Metabolic Dysfunction-Associated Steatotic Liver Disease

## Interventions

- **DEVICE:** Gro Health digital application

## Key facts

- **NCT ID:** NCT06920316
- **Lead sponsor:** St. George's Hospital, London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2027-05
- **Final completion:** 2027-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920316, "Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06920316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*